# Forensic Dossier: Study Forensics: Vitamin D supplements and long COVID

**Run ID:** `val_study-forensics-007_claude_haiku_204086`  
**Task:** study-forensics-007 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-06T14:26:19.218679+00:00  
**Task Family:** overclaim  
**Trap Type:** small_effect_overinterpretation  
**Ambiguity:** medium  

## Executive Summary

**Agents tested:** Claude Haiku
**Winner:** Claude Haiku — **40.0/100** (margin: 0.0)
**Failure modes:** unsupported_conclusion, wrong_answer
**Forensic flags:** 3
**Consistency findings:** 7
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Haiku | 0.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.9/6 | 4.5/6 | 6.4/8 | 8.0/8 | 4.0/10 | 10.0/10 | **40.0/100** |

## Study Forensics Audit

### Claude Haiku

**Classification:** `solid` [x] (gold: `overclaim`)
**Finding Recall:** 100%
**Matched Findings:** conclusion_exceeds_results, decorative_uncertainty
**Extra Findings:** cautious_scope_control, none_or_minor, mechanism_not_demonstrated, correlation_as_causation

## Reasoning Integrity Audit

### Claude Haiku
**Classification:** Correct and well-supported
**Load-bearing steps:** 0 / 8

## Mechanism Analysis

### Claude Haiku
| Aspect | Status |
|--------|--------|
| Concept named | :white_check_mark: effect |
| Mechanism described | :white_check_mark: (1 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** mechanism not grounded to case data

## Grounding Audit

### Claude Haiku
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "solid"


## Forensic Flags

### Claude Haiku

- **[MAJOR]** `well_reasoned_wrong`: Wrong answer but structured reasoning — may have a subtle logic error
  - `final_answer`: "solid"
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "solid"
- **[MODERATE]** `ungrounded_mechanism`: Mechanism named/described but not connected to case-specific data
  - `(mechanism analysis)`: "effect"


## Evidence Map

### Claude Haiku

**Correctness:** 0.0/30
  - (+) `final_answer`: "solid"
    _Agent's answer for correctness check_
  - Note: No match (got: solid)

**Support Strength:** 0.0/8
  - (-) `final_answer`: "solid"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 8
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[1]`: "Examined primary outcome claim: vitamin D did NOT change acute infection severity—this is a null finding presented strai"
    _Most informative reasoning step_
  - Note: 8 reasoning steps
  - Note: Low step utility: 0/8 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[0]`: "The study was a properly randomized controlled trial with appropriate blinding and allocation concealment (standard for "
    _Most substantive assumption_
  - Note: 5/5 substantive assumptions

**Uncertainty Handling:** 3.9/6
  - (+) `uncertainties[0]`: "Whether the 4-percentage-point difference is statistically significant (confidence interval not provided in the summary)"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.88"
    _Stated confidence level_
  - Note: 4 uncertainties (4 substantive)
  - Note: Confidence 0.88

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[1]`: "Correlation vs causation: if the text claimed vitamin D *caused* the reduction without acknowledging the observational n"
    _Most substantive alternative hypothesis_
  - Note: 3 alternative hypotheses considered
  - Note: 3/3 genuinely diverse alternatives

**Self Monitoring Quality:** 6.4/8
  - (+) `self_check[1]`: "Did I flag the 4-point difference as clinically meaningful? No—the text does not claim this; it calls for larger trials"
    _Most substantive self-verification step_
  - Note: 6 self-check items
  - Note: Self-check quality: 0 deep, 6 arithmetic, 0 fluff

**Mechanism Quality:** 4.0/10
  - (+) `(mechanism analysis)`: "Evaluated mechanism claims: none are made; no mechanism is invoked to explain the difference"
    _Mechanism description without case grounding_
  - Note: Names concept + describes mechanism (not grounded to case)

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.71, 456 words

**Insight Depth:** 2.7/8
  - (+) `(output text)`: "in the difference checked for decorative uncertainty: the call for larger trials i"
    _Insight 'decorative uncertainty' matched (exact)_
  - (?) `(not found)`: "Missing: null primary outcome"
    _Insight 'null primary outcome' not found_
  - Note: Key insights: 1 full / 3


## Failure Analysis

### Claude Haiku

**CRITICAL:**
- **Wrong Answer** `[HIGH CONFIDENCE]`: Answer does not match expected 'overclaim'
  - `final_answer`: "solid"
  - _Impacts: correctness_

**MAJOR:**
- **Wrong Answer** `[HIGH CONFIDENCE]`: Study classification incorrect: expected 'overclaim', detected 'solid'
  - `final_answer`: "solid"
  - _Impacts: correctness_

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "solid"
  - _Impacts: support_strength_


## Consistency & Grounding Audit

### Claude Haiku

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/9 content words)
  - `key_claims[0]`: "The primary outcome (acute severity) showed no effect—this is clearly stated and not overclaimed"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/9 content words)
  - `key_claims[1]`: "A secondary outcome (lingering symptoms) showed a 4-percentage-point difference favoring vitamin D"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/11 content words)
  - `key_claims[2]`: "The senior author appropriately labeled this a 'promising signal' rather than a finding, and called "
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/8 content words)
  - `key_claims[3]`: "Limitations (remote conduct, post-infection start) are explicitly acknowledged, not hidden"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "Overclaim: if the 4-point difference were presented as clinically meaningful without acknowledging i"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "Correlation vs causation: if the text claimed vitamin D *caused* the reduction without acknowledging"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 3 is stated without rejection reasoning
  - `alternative_hypotheses[2]`: "Mechanism vs evidence: if a biological mechanism were invoked to explain the lingering symptom diffe"


## Agent Profiles

### Claude Haiku (claude-haiku-4-5-20251001)
**Parse OK:** True | **Latency:** 14670ms

**Final Answer:** solid

**Confidence:** 0.88

**Assumptions:**
- The study was a properly randomized controlled trial with appropriate blinding and allocation concealment (standard for RCTs)
- The 1,747 sample size is adequate for detecting the primary outcome (acute severity)
- The 4-percentage-point difference (25% vs 21%) in lingering symptoms is the actual observed effect
- The remote conduct and post-infection timing are acknowledged limitations rather than hidden methodological flaws
- The senior author's 'promising signal' language reflects appropriate caution given the secondary nature of this finding

**Reasoning Steps:**
1. Identified the study design: RCT with 1,747 participants—a reasonably large, well-controlled design
2. Examined primary outcome claim: vitamin D did NOT change acute infection severity—this is a null finding presented straightforwardly
3. Examined secondary outcome: 4-percentage-point difference in lingering symptoms at 8 weeks (21% vs 25%)
4. Evaluated the language used: 'promising signal' is appropriately tentative language for a secondary outcome with modest effect size
5. Checked for causal claims: the text does not claim causation; it reports an association and calls for larger trials
6. Assessed confounders: remote conduct and post-infection start are noted as limitations, not hidden
7. Evaluated mechanism claims: none are made; no mechanism is invoked to explain the difference
8. Checked for decorative uncertainty: the call for larger trials is substantive, not decorative—it's appropriate given a secondary finding

**Key Claims:**
- The primary outcome (acute severity) showed no effect—this is clearly stated and not overclaimed
- A secondary outcome (lingering symptoms) showed a 4-percentage-point difference favoring vitamin D
- The senior author appropriately labeled this a 'promising signal' rather than a finding, and called for larger trials
- Limitations (remote conduct, post-infection start) are explicitly acknowledged, not hidden

**Alternative Hypotheses:**
- Overclaim: if the 4-point difference were presented as clinically meaningful without acknowledging it's a secondary outcome and modest in size
- Correlation vs causation: if the text claimed vitamin D *caused* the reduction without acknowledging the observational nature of the secondary analysis
- Mechanism vs evidence: if a biological mechanism were invoked to explain the lingering symptom difference without evidence

**Uncertainties:**
- Whether the 4-percentage-point difference is statistically significant (confidence interval not provided in the summary)
- Whether this was a pre-specified secondary outcome or post-hoc analysis (affects interpretation of 'promising signal')
- The actual effect size and clinical meaningfulness of a 4-point difference in symptom prevalence
- Whether the remote conduct introduced systematic bias in symptom reporting

**Self-Verification:**
- Did I flag 'promising signal' as overclaim? No—it's appropriately cautious language for a secondary finding
- Did I flag the 4-point difference as clinically meaningful? No—the text does not claim this; it calls for larger trials
- Did I assume statistical significance without evidence? No—I noted this as an uncertainty
- Did I miss any causal language? No—the text reports associations and calls for further research
- Did I fabricate confounders? No—I only noted those explicitly mentioned (remote conduct, timing)
- Is the acknowledgment of limitations genuine or decorative? Genuine—they are real constraints on interpretation

**Dimension Scores:**
- Correctness: 0.0/30 `..........`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.9/6 `######....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 6.4/8 `########..`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 4.0/10 `####......`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Haiku** scored **40.0/100**.

**Best per dimension:**
- Correctness: Claude Haiku (0.0/30)
- Support Strength: Claude Haiku (0.0/8)
- Structural Reasoning: Claude Haiku (4.8/8)
- Assumption Discipline: Claude Haiku (4.8/6)
- Uncertainty Handling: Claude Haiku (3.9/6)
- Alternative Hypothesis Quality: Claude Haiku (4.5/6)
- Self Monitoring Quality: Claude Haiku (6.4/8)
- Insight Depth: Claude Haiku (8.0/8)
- Mechanism Quality: Claude Haiku (4.0/10)
- Communication Efficiency: Claude Haiku (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Haiku | 14.7s | 40.0/100 | 2.7 |

Failure modes observed: unsupported_conclusion, wrong_answer.
